SCHEMBL786920

SCHEMBL786920

CCON(C)CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL28211134 0.97
Hydrochloric Acid SCHEMBL7085472 0.97
Sulfuric Acid SCHEMBL28101970 0.84 TP53 (0.31)
SCHEMBL28090390 0.78
SCHEMBL27523351 0.73
SCHEMBL11851480 0.73
SCHEMBL7054555 0.73
SCHEMBL21089331 0.73
SCHEMBL28035563 0.71
SCHEMBL12738544 0.71 ALDH1A1 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4713389-A Fungicidally and bactericidally active acylated saccharin derivatives BAYER AKTIENGESELLSCHAFT (DE) 1987-12-15 US claimed
US-12371454-B2 Cyclic peptide compound having Kras inhibitory action CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2025-07-29 US disclosed
US-20240400617-A1 CYCLIC PEPTIDE COMPOUND HAVING KRAS INHIBITORY ACTION CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2024-12-05 US disclosed
US-20240148821-A1 PHARMACEUTICAL USE OF CYCLIC PEPTIDE COMPOUND CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2024-05-09 US disclosed
EP-4316503-A1 PHARMACEUTICAL USE OF CYCLIC PEPTIDE COMPOUND CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2024-02-07 EP disclosed
CN-117279655-A Pharmaceutical use of cyclic peptide compounds 中外制药株式会社 2023-12-22 CN disclosed
US-20230151060-A1 CYCLIC PEPTIDE COMPOUND HAVING KRAS INHIBITORY ACTION CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2023-05-18 US disclosed
WO-2022234852-A1 PHARMACEUTICAL USE OF CYCLIC PEPTIDE COMPOUND 中外製薬株式会社 2022-11-10 WO disclosed
EP-4043478-A1 CYCLIC PEPTIDE COMPOUND HAVING KRAS INHIBITING ACTION CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2022-08-17 EP disclosed
US-20170183369-A1 CATALYSTS AND METHODS FOR POLYMER SYNTHESIS SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) 2017-06-29 US disclosed
US-20070232768-A1 Alkoxyamines Containing a Radically Polymerizable Group CIBA SPECIALTY CHEMICALS CORP. 2007-10-04 US disclosed
US-7256165-B2 Cleaning compositions THE PROCTER & GAMBLE COMPANY (US) 2007-08-14 US disclosed
US-20050183204-A1 Fabric care composition for directly applying to fabrics GUARIN LEDA M P (PH) 2005-08-25 US disclosed
EP-1448198-A1 NICOTIN-OR ISONICOTIN BENZOTHIAZOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-08-25 EP disclosed
US-6620811-B2 Adenosine receptor antagonists; nervous system and cardiovascular disorders; Parkinson*s, Huntington*s, and Alzheimer* disease; antiasthmatics, antiallergens HOFFMANN-LA ROCHE INC. 2003-09-16 US disclosed
US-20030134854-A1 Isonicotin- and nicotinamide derivatives of benzothiazoles F.HOFFMANN-LA ROCHE AG (CH) 2003-07-17 US disclosed
WO-2003043636-A1 NICOTIN-OR ISONICOTIN BENZOTHIAZOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2003-05-30 WO disclosed
EP-0101873-B1 METHOD FOR MODIFYING UNSATURATED RUBBERS AND PRODUCT OBTAINED THEREBY GENERAL ELECTRIC COMPANY (US) 1987-09-16 EP disclosed
US-4517341-A AMINE CATALYST GENERAL ELECTRIC COMPANY (US) 1985-05-14 US disclosed
EP-0101873-A2 Method for modifying unsaturated rubbers and product obtained thereby GENERAL ELECTRIC COMPANY (US) 1984-03-07 EP disclosed